Full Press Release Details
TARRYTOWN, N.Y.,July 18, 2016/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast a management presentation at the following investor conference:
• 36thAnnual Canaccord Genuity Growth Conference at11:30 a.m. Eastern TimeonThursday, August 11, 2016
The session may be accessed through the Company's web site,www.regeneron.com, on the 'Events and Presentations' page. Archived versions of the presentation will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.Regeneron (NASDAQ:REGN) is a leading science-based biopharmaceutical company based inTarrytown, New Yorkthat discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer and infectious diseases. For additional information about the company, please visitwww.regeneron.comor follow @Regeneron on Twitter.
| Contact Information: | |
| Investor Relations | Corporate Communications |
| Manisha Narasimhan, Ph.D. | Hala Mirza |
| 914.847.5126 | 914.847.3422 |
| [email protected] | [email protected] |
[email protected]
[email protected]